Form 8-K - Current report:
SEC Accession No. 0001600620-25-000083
Filing Date
2025-06-30
Accepted
2025-06-30 06:03:53
Documents
31
Period of Report
2025-06-30
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K auph-20250630.htm   iXBRL 8-K 30421
2 EX-99.1 exhibit991_2025june30phase.htm EX-99.1 10740
3 EX-99.2 aritinerceptresultsfromp.htm EX-99.2 16403
7 aritinerceptresultsfromp001.jpg GRAPHIC 56563
8 aritinerceptresultsfromp002.jpg GRAPHIC 196256
9 aritinerceptresultsfromp003.jpg GRAPHIC 127280
10 aritinerceptresultsfromp004.jpg GRAPHIC 128784
11 aritinerceptresultsfromp005.jpg GRAPHIC 101332
12 aritinerceptresultsfromp006.jpg GRAPHIC 131953
13 aritinerceptresultsfromp007.jpg GRAPHIC 126854
14 aritinerceptresultsfromp008.jpg GRAPHIC 93185
15 aritinerceptresultsfromp009.jpg GRAPHIC 110678
16 aritinerceptresultsfromp010.jpg GRAPHIC 77984
17 aritinerceptresultsfromp011.jpg GRAPHIC 119531
18 aritinerceptresultsfromp012.jpg GRAPHIC 119439
19 aritinerceptresultsfromp013.jpg GRAPHIC 120818
20 aritinerceptresultsfromp014.jpg GRAPHIC 121863
21 aritinerceptresultsfromp015.jpg GRAPHIC 66069
22 aritinerceptresultsfromp016.jpg GRAPHIC 42734
23 auphlogoregistereda.jpg GRAPHIC 17097
  Complete submission text file 0001600620-25-000083.txt   2606244

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT auph-20250630.xsd EX-101.SCH 1813
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT auph-20250630_lab.xml EX-101.LAB 21629
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT auph-20250630_pre.xml EX-101.PRE 12532
33 EXTRACTED XBRL INSTANCE DOCUMENT auph-20250630_htm.xml XML 2720
Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

EIN.: 981231763 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36421 | Film No.: 251088641
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)